Literature DB >> 34637049

Mycobacterium tuberculosis strain lineage in mixed tribal population across India and Andaman Nicobar Island.

Azger Dusthackeer1, Ashok Kumar2, Sucharitha Kannappan Mohanvel3, B Mahizhaveni2, S Shivakumar2, S Raghavi4, S Azhagendran4, S Vetrivel4, Vikas Gangadhar Rao5, Rajiv Yadav5, Vijayachari Paluru6, Anil Jacob Purthy7, Tahziba Hussain8, Vivek Kashyap9, K Rekha Devi10, Anil Kumar Indira Krishnan11, Praveen Anand12, Pradeep Das13, Avi Kumar Bansal14, Madhuchhanda Das15, Harpreet Kaur15, D Raghunath16, Rajesh Mondal17, Beena E Thomas4.   

Abstract

In India, the tribal population constitutes almost 8.6% of the nation's total population. Despite their large presence, there are only a few reports available on Mycobacterium tuberculosis (M. tb) strain prevalence in Indian tribal communities considering the mobile nature of this population and also the influence of the mainstream populations they coexist within many areas for their livelihood. This study attempts to provide critical information pertaining to the TB strain diversity, its public health implications, and distribution among the tribal population in eleven Indian states and Andaman & Nicobar (A&N) Island. The study employed a population-based molecular approach. Clinical isolates were received from 66 villages (10 states and Island) and these villages were selected by implying situation analysis. A total of 78 M. tb clinical isolates were received from 10 different states and A&N Island. Among these, 16 different strains were observed by spoligotyping technique. The major M. tb strains spoligotype belong to the Beijing, CAS1_DELHI, and EAI5 family of M. tb strains followed by EAI1_SOM, EAI6_BGD1, LAM3, LAM6, LAM9, T1, T2, U strains. Drug-susceptibility testing (DST) results showed almost 15.4% of clinical isolates found to be resistant to isoniazid (INH) or rifampicin (RMP) + INH. Predominant multidrug-resistant (MDR-TB) isolates seem to be Beijing strain. Beijing, CAS1_DELHI, EAI3_IND, and EAI5 were the principal strains infecting mixed tribal populations across India. Despite the small sample size, this study has demonstrated higher diversity among the TB strains with significant MDR-TB findings. Prevalence of Beijing MDR-TB strains in Central, Southern, Eastern India and A&N Island indicates the transmission of the TB strains.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Clusters; Lineage; M. tuberculosis; Prevalence; Spoligotyping; Tribe

Mesh:

Substances:

Year:  2021        PMID: 34637049     DOI: 10.1007/s11274-021-03164-6

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  13 in total

1.  Prevalence of pulmonary tuberculosis amongst the tribal population of Madhya Pradesh, central India.

Authors:  Jyothi Bhat; Vikas G Rao; Punnathanathu Gopalan Gopi; Rajiv Yadav; Nagamiah Selvakumar; Balkrishna Tiwari; Vijay Gadge; Manoj K Bhondeley; Fraser Wares
Journal:  Int J Epidemiol       Date:  2009-06-09       Impact factor: 7.196

2.  Trends in drug-resistant Mycobacterium tuberculosis in New York City, 1991-2003.

Authors:  Sonal S Munsiff; Jiehui Li; Sharlette V Cook; Amy Piatek; Fabienne Laraque; Adeleh Ebrahimzadeh; Paula I Fujiwara
Journal:  Clin Infect Dis       Date:  2006-05-12       Impact factor: 9.079

3.  Evaluation of p-nitro benzoic acid (pnb) inhibition test to differentiate Mycobacterium tuberculosis complex from non-tuberculous mycobacteria using microscopic observation of drug susceptibility (MODS) methodology.

Authors:  A Agarwal; T N Dhole; Y K Sharma
Journal:  Indian J Tuberc       Date:  2014-07

4.  Declining tuberculosis prevalence in Saharia, a particularly vulnerable tribal community in Central India: evidences for action.

Authors:  V G Rao; J Bhat; R Yadav; R K Sharma; M Muniyandi
Journal:  BMC Infect Dis       Date:  2019-02-20       Impact factor: 3.090

5.  Two tales: Worldwide distribution of Central Asian (CAS) versus ancestral East-African Indian (EAI) lineages of Mycobacterium tuberculosis underlines a remarkable cleavage for phylogeographical, epidemiological and demographical characteristics.

Authors:  David Couvin; Yann Reynaud; Nalin Rastogi
Journal:  PLoS One       Date:  2019-07-12       Impact factor: 3.240

6.  Molecular diversity of Mycobacterium tuberculosis complex in Sikkim, India and prediction of dominant spoligotypes using artificial intelligence.

Authors:  Kangjam Rekha Devi; Jagat Pradhan; Rinchenla Bhutia; Peggy Dadul; Atanu Sarkar; Nitumoni Gohain; Kanwar Narain
Journal:  Sci Rep       Date:  2021-04-01       Impact factor: 4.379

7.  Molecular epidemiology of Mycobacterium tuberculosis complex in the Volta Region of Ghana.

Authors:  Selassie Ameke; Prince Asare; Samuel Yaw Aboagye; Isaac Darko Otchere; Stephen Osei-Wusu; Dorothy Yeboah-Manu; Adwoa Asante-Poku
Journal:  PLoS One       Date:  2021-03-17       Impact factor: 3.240

8.  A study of Mycobacterium tuberculosis genotypic diversity & drug resistance mutations in Varanasi, north India.

Authors:  Anamika Gupta; Savita Kulkarni; Nalin Rastogi; Shampa Anupurba
Journal:  Indian J Med Res       Date:  2014-06       Impact factor: 2.375

9.  Genetic Diversity of Mycobacterium tuberculosis Isolates from Assam, India: Dominance of Beijing Family and Discovery of Two New Clades Related to CAS1_Delhi and EAI Family Based on Spoligotyping and MIRU-VNTR Typing.

Authors:  Kangjam Rekha Devi; Rinchenla Bhutia; Shovonlal Bhowmick; Kaustab Mukherjee; Jagadish Mahanta; Kanwar Narain
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

10.  A sister lineage of the Mycobacterium tuberculosis complex discovered in the African Great Lakes region.

Authors:  Jean Claude Semuto Ngabonziza; Chloé Loiseau; Michael Marceau; Agathe Jouet; Fabrizio Menardo; Oren Tzfadia; Rudy Antoine; Esdras Belamo Niyigena; Wim Mulders; Kristina Fissette; Maren Diels; Cyril Gaudin; Stéphanie Duthoy; Willy Ssengooba; Emmanuel André; Michel K Kaswa; Yves Mucyo Habimana; Daniela Brites; Dissou Affolabi; Jean Baptiste Mazarati; Bouke Catherine de Jong; Leen Rigouts; Sebastien Gagneux; Conor Joseph Meehan; Philip Supply
Journal:  Nat Commun       Date:  2020-06-09       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.